Cosmos Health Inc. (NASDAQ: COSM) announced that its subsidiary Cana Laboratories S.A. has acquired international patent application WO2025108566A1 from Cloudpharm ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE